Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000042

Chief Operating Officer sold 15,982 shares at an average $15.42 ($246,403)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J Chief Operating Officer 2023-06-20 Sale 10b5-1 −8,885 $14.94 $132,704 49,570 D: show line 1 in the form
Dowden Nathan J Chief Operating Officer 2023-06-22 Sale 10b5-1 −7,097 $16.02 $113,700 42,473 D: show line 2 in the form
Open-market sales · 15,982 sh · avg $15.42 · $246,403
Loading xslF345X04/wf-form4_168746675476462.xml…